GlassScriptPhysician profile
Armin Arshi
NPI 1790148070
$9,645.41
in general payments reported to CMS, 2019-2025
9 companies · $907 in 2025
The $907 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,339 · 2022: $4,361 · 2023: $551 · 2024: $487 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Travel and Lodging: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.41 |
| Travel and Lodging | $161.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,709.15 | 2021-2025 | Pico 14, Pico 7 |
| Stryker Corporation | $2,372.02 | 2022-2025 | Mako, Insignia, Triathlon |
| Depuy Synthes Sales INC. | $201.57 | 2022-2025 | Na, Tfn-Advance |
| Davol INC. | $158.89 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $81.44 | 2024-2025 | |
| Bioventus LLC | $38.99 | 2025 | Xcell |
| Solventum Corporation | $36.64 | 2025 | Prevena Restor Axioform, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Radius Health, INC. | $23.50 | 2025 | Tymlos |
| Amgen INC. | $23.21 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armin Arshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.